Champignon Brands Inc. SHRMF Archives - Page 4 of 4

TuesdayApr 28, 2020 10:15 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Chosen as Headline Partner for PSYCH: The Psychedelics Symposium

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced that it has been chosen as the Headline Partner for Prohibition Partners LIVE’s PSYCH: The Psychedelics Symposium (“PSYCH”). The psychedelics virtual conference, scheduled to take place June 22 - 23, 2020, will highlight the most recent developments in the psychedelic industry, hear from world-renowned speakers and engage with a network of industry-leading professionals. “The impact of COVID-19 has put greater emphasis on…

ThursdayApr 23, 2020 12:38 pm

Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Announces Acquisition of Canada’s Only Approved Psychedelic Medicine Clinic

SHRM to acquire AltMed Capital Corp, a Canadian ketamine clinic operator, psychedelic medicine IP aggregator and novel drug discoverer Champignon to roll out five unique ketamine clinics across Florida, California and the U.S. Eastern seaboard CRTCE is only center worldwide to demonstrate rapid onset treatments improve health outcomes within weeks Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a Canada-based company dedicated applying novel and natural treatment protocols with an emphasis on psychedelic medicine, has entered into a definitive agreement to acquire AltMed Capital Corp, a Canadian ketamine clinic operator, psychedelic medicine IP aggregator and novel drug discoverer (http://ibn.fm/AZedG). The…

FridayApr 17, 2020 1:50 pm

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Secures DTC Eligibility

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced that its common shares are now fully eligible for electronic clearing and settlement through the Depository Trust Company (“DTC”). Champignon’s common shares will continue to trade under the ticker symbol “SHRMF” on the OTC Markets. “We are actively engaged in pursuing new avenues of distribution both in North America and internationally, in order to enhance the ability of larger audiences to participate…

TuesdayApr 14, 2020 11:33 am

Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Expands Reach into Preclinical Trials, Alternative Medicine

Dedicated to the health-conscious consumer Expanded preclinical trial pipeline by entering into definitive agreement to acquire Tassili Life Sciences Corp Expanding brand into alternative medicine by entering into a definitive agreement to acquire Novoformulations Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a Canada-based company dedicated to the distribution of artisanal medicinal mushroom-infused products, is expanding its portfolio with the health-conscious consumer in mind. SHRM recently entered into a definitive agreement to acquire two separate companies: Tassili Life Sciences Corp. and Novoformulations, a specialty biotechnology company. SHRM recently announced it has expanded its preclinical trial pipeline by entering into…

Site Search

Company Search

Tag: Champignon Brands Inc. SHRMF

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Chosen as Headline Partner for PSYCH: The Psychedelics Symposium

Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Announces Acquisition of Canada’s Only Approved Psychedelic Medicine Clinic

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Secures DTC Eligibility

Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Expands Reach into Preclinical Trials, Alternative Medicine

Market Basics

Newsletter Publishers

Public Companies